Hematological Malignancies
Showing NaN - NaN of 11
Hematological Malignancies Trial in Worldwide (Pembrolizumab/vibostolimab coformuation)
Recruiting
- Hematological Malignancies
- Pembrolizumab/vibostolimab coformuation
-
Duarte, California
- +64 more
Jan 27, 2023
Hematological Malignancies Trial in United Kingdom, United States (Magrolimab, Azacitidine)
Active, not recruiting
- Hematological Malignancies
- Magrolimab
- Azacitidine
-
Duarte, California
- +26 more
Dec 7, 2022
Hematological Malignancies Trial in Georgia, Poland, United States (Tenalisib)
Enrolling by invitation
- Hematological Malignancies
-
San Francisco, California
- +6 more
Nov 1, 2021
Hematological Malignancies, Myelodysplastic Syndrome, Leukemia Trial in Houston (Mycophenolate Mofetil (MMF), Thymoglobulin,
Terminated
- Hematological Malignancies
- +3 more
- Mycophenolate Mofetil (MMF)
- +3 more
-
Houston, TexasUT MD Anderson Cancer Center
Sep 1, 2020
Hematological Malignancies Trial in Houston (ABT-751)
Completed
- Hematological Malignancies
-
Houston, TexasThe University of Texas M.D. Anderson Cancer Center
Oct 30, 2018
Hematological Malignancies Trial in Houston (Ibandronate, Vitamin Supplements)
Completed
- Hematological Malignancies
- Ibandronate
- Vitamin Supplements
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 12, 2018
Hematological Malignancies Trial in Washington, Houston, Toronto (Obatoclax mesylate (GX15-070MS))
Completed
- Hematological Malignancies
- Obatoclax mesylate (GX15-070MS)
-
Washington, District of Columbia
- +2 more
May 9, 2014
Hematological Malignancies Trial in Houston (Ribavirin)
Completed
- Hematological Malignancies
-
Houston, TexasU.T.M.D. Anderson Cancer Center
Jul 27, 2012